ATM was the flop. Cantrixil is still on the cards, gdc-0084 latest scientific data and research shows why you're view is outdated and irrelevant. Lastly nox is paying for its failure of due diligence and Kza is simply making cream for there lack. Spin it however you like nox is paying us not the other way round. Nox has no granted or secured IP and anyway forward is done via remuneration to kza. Whose fault was that?
ATM was the flop. Cantrixil is still on the cards, gdc-0084...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 52445 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 14000 | 1 |
View Market Depth
| Last trade - 16.12pm 27/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable
